Hopp til innhold

Get alerts of updates about «Mapping of methods to increase participation in diabetic retinopathy screening»

How often would you like to receive alerts from fhi.no? (This affects all your alerts)
Do you also want alerts about:

The email address you register will only be used to send you these alerts. You can cancel your alerts and delete your email address at any time by following the link in the alerts you receive.
Read more about the privacy policy for fhi.no

You have subscribed to alerts about:

  • Mapping of methods to increase participation in diabetic retinopathy screening

Mapping review

Mapping of methods to increase participation in diabetic retinopathy screening

Published

We have mapped methods to increase screening participation in diabetic retinopathy.

Forside diabetisk retinopati.jpg

We have mapped methods to increase screening participation in diabetic retinopathy.


Downloadable as PDF. In Norwegian. English summary.

About this publication

  • Year: 2020
  • By: Norwegian Institute of Public Health
  • Authors Ohm IK, Næss GE, Fretheim A, Lerner MR.
  • ISBN (digital): 978-82-8406-131-3

Key message

Diabetic retinopathy is a microvascular complication of diabetes mellitus, caused by persistent high blood sugar levels that damage blood vessels and nerves in the retina. Without treatment, diabetic retinopathy could ultimately lead to blindness. Even though regular screening has been shown to reduce the incidence of vision loss as a result of diabetic retinopathy, too few people with diabetes are routinely being screened.

  • Participation in screening for diabetic retinopathy can be increased through different interventions, including reminders and strategies using telemedicine screening without mydriatic dilatation.
  • Factors that can affect screening participation include availability, knowledge, age, symptoms, and education. Actions that address these factors can thus help to increase screening participation.
  • There are more recent clinical studies that investigate the effect of different methods with regards to screening participation, including reminders, telemedicine methods, and incentives.
  • We have found few ongoing, clinical studies and systematic reviews that investigate this outcome.